VESPER Trial: A Recurrent UTI Prevention Clinical Trial, with Professor Chris Harding

Would you join a clinical trial for recurrent urinary tract infection prevention? In order to address the gaps in recurrent UTI prevention research, the VESPER trial is comparing two treatments administered directly into the bladder (intravesical treatment) to prevent UTI, against the current recommended treatment approach. In this interview, Professor Chris Harding shares more information about the trial and how to join, including answering the following: 👉 What are the three treatments that the trial will compare? 👉 How are treatments delivered directly to the bladder? 👉 What is the GAG layer and how is it connected to recurrent UTI? 👉 How safe is it to instill antibiotics into the bladder? 👉 Who is eligible to participate in the clinical trial? 👉 Do candidates need to have symptoms of a UTI at the time of joining the trial? 👉 How can someone join the trial? 👉 Is participation free of charge? 👉 Can participants take any other over-the-counter UTI preventatives while participating in the trial? Learn more about the VESPER trial: https://liveutifree.com/VESPER-trial *About Professor Chris Harding* Harding is a Consultant Urological Surgeon at Newcastle upon Tyne Hospitals NHS Foundation Trust and Professor of Urology at Newcastle University. He trained at the University of Cambridge, Addenbrookes Hospital Cambridge, Kings College London and Freeman Hospital Newcastle. He has a particular interest in bladder dysfunction, continence, neurourology, urinary tract infections, mesh complications and clinical research. He is Chair of the NIHR National Benign Urology group and Urology lead for the Department of Health Modernising Scientific Careers programme. He is also current Chair of the European Association of Urology Guidelines Panel for Female Non-Neurogenic Lower Urinary Tract Symptoms and also past Chairman of the executive committee of the British Association of Urological Surgeons Female Neurological and Urodynamic Urology subsection. He sits on the International Continence Society Urodynamics, Conservative Management of Male LUTS and Mesh Complications Committees. In 2020 he was awarded the BAUS Golden Telescope for “a significant and lasting contribution to Urology”. *About Live UTI Free* Live UTI Free is a patient advocacy and research organization. We provide research support, recruitment for research, and free resources for patient and clinician education on topics within women's pelvic health, with a focus on UTI. We do our best to provide patients with information about clinicians who specialize in recurrent and chronic UTI, in different regions. Patients, clinicians and researchers are welcome to reach out: https://liveutifree.com/contact Post-production: Melissa Wairimu   / kreativlee_   *Disclaimer* The opinions presented in this video do not necessarily reflect the opinions of the Live UTI Free team. Live UTI Free does not endorse specific treatment approaches, clinicians or diagnostics methods. The content of this video does not provide medical advice. It is intended for informational purposes only. The medical and/or nutritional information is not a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen.